MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-10-2022
Viveve Medical Operating Income 2011-2026 | VIVE
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -21.6 M | -18.5 M | -30.7 M | -45 M | -33.7 M | -18.7 M | -12 M | -5.66 M | -3.93 M | -4.12 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.93 M | -45 M | -19.4 M |
Quarterly Operating Income Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -4.66 M | -5.02 M | -5.47 M | - | -5.49 M | -4.94 M | -5.13 M | - | -3.4 M | -4.94 M | -5.83 M | - | -6.53 M | -8.32 M | -8.78 M | - | -11.1 M | -10.3 M | -11.3 M | - | -8.82 M | -9.06 M | -6.42 M | - | -4.64 M | -4.54 M | -4 M | - | -3.1 M | -2.89 M | -2.43 M | - | -2.36 M | -1.19 M | -976 K | - | -706 K | -1.29 M | -1.07 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -706 K | -11.3 M | -5.16 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.3 | -4.96 % | $ 6.38 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Align Technology
ALGN
|
608 M | $ 166.05 | -6.36 % | $ 12.4 B | USA |
 |
Sensus Healthcare
SRTS
|
-10.3 M | $ 3.79 | -5.61 % | $ 61.9 M | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 328.87 | -1.15 % | $ 126 B | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 10.97 | -4.78 % | $ 1.65 B | USA |
 |
Tactile Systems Technology
TCMD
|
29.3 M | $ 26.49 | -1.08 % | $ 606 M | USA |
 |
TELA Bio
TELA
|
-33.8 M | $ 0.67 | -10.47 % | $ 31.5 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
7.84 M | $ 0.38 | 1.99 % | $ 39.1 M | USA |
 |
Abbott Laboratories
ABT
|
8.05 B | $ 104.91 | 0.33 % | $ 183 B | USA |
 |
Tandem Diabetes Care
TNDM
|
8.29 M | $ 21.24 | -8.92 % | $ 1.44 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 69.46 | -1.01 % | $ 103 B | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 35.4 | -3.38 % | $ 1.1 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-39 M | $ 56.7 | -5.36 % | $ 1.68 B |  Costa-rica |
 |
NanoVibronix
NAOV
|
-3.58 M | - | - | $ 1.08 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Viemed Healthcare
VMD
|
22.9 M | $ 9.27 | 0.54 % | $ 361 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.61 | 1.65 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.14 | -5.73 % | $ 3.34 M | USA |
 |
Varex Imaging Corporation
VREX
|
-27.8 M | $ 10.82 | 0.32 % | $ 448 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 79.47 | -3.2 % | $ 46.5 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Beyond Air
XAIR
|
-44.5 M | $ 0.72 | 4.06 % | $ 48.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
-12.1 M | $ 0.55 | -2.12 % | $ 73.5 M | USA |
 |
Inogen
INGN
|
-30.2 M | $ 6.29 | -3.31 % | $ 167 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
1.29 B | $ 88.46 | -0.77 % | $ 18 B | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 11.16 | -2.19 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 15.81 | -3.3 % | $ 371 M | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-27 M | - | 10.0 % | $ 610 K | USA |